Barbieri JT - Search Results

1

Botulinum Neurotoxin A4 Has a 1000-Fold Reduced Potency Due to Three Single Amino Acid Alterations in the Protein Receptor Binding Domain.

Tepp WH, Bradshaw M, Gardner AP, Kaufman RL, Barbieri JT, Pellett S. Tepp WH, et al. Among authors: barbieri jt. Int J Mol Sci. 2023 Mar 16;24(6):5690. doi: 10.3390/ijms24065690. Int J Mol Sci. 2023. PMID: 36982762 Free PMC article.

2

Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes A and E.

Baldwin MR, Tepp WH, Pier CL, Bradshaw M, Ho M, Wilson BA, Fritz RB, Johnson EA, Barbieri JT. Baldwin MR, et al. Among authors: barbieri jt. Infect Immun. 2005 Oct;73(10):6998-7005. doi: 10.1128/IAI.73.10.6998-7005.2005. Infect Immun. 2005. PMID: 16177380 Free PMC article.

3

Resolution of Two Steps in Botulinum Neurotoxin Serotype A1 Light Chain Localization to the Intracellular Plasma Membrane.

Gardner A, Tepp WH, Bradshaw M, Barbieri JT, Pellett S. Gardner A, et al. Among authors: barbieri jt. Int J Mol Sci. 2021 Oct 15;22(20):11115. doi: 10.3390/ijms222011115. Int J Mol Sci. 2021. PMID: 34681775 Free PMC article.

4

How Botulinum Neurotoxin Light Chain A1 Maintains Stable Association with the Intracellular Neuronal Plasma Membrane.

Gardner AP, Barbieri JT, Pellett S. Gardner AP, et al. Among authors: barbieri jt. Toxins (Basel). 2022 Nov 22;14(12):814. doi: 10.3390/toxins14120814. Toxins (Basel). 2022. PMID: 36548711 Free PMC article.

5

The C-terminus of botulinum neurotoxin type A light chain contributes to solubility, catalysis, and stability.

Baldwin MR, Bradshaw M, Johnson EA, Barbieri JT. Baldwin MR, et al. Among authors: barbieri jt. Protein Expr Purif. 2004 Sep;37(1):187-95. doi: 10.1016/j.pep.2004.05.009. Protein Expr Purif. 2004. PMID: 15294297

6

Recombinant holotoxoid vaccine against botulism.

Pier CL, Tepp WH, Bradshaw M, Johnson EA, Barbieri JT, Baldwin MR. Pier CL, et al. Among authors: barbieri jt. Infect Immun. 2008 Jan;76(1):437-42. doi: 10.1128/IAI.00843-07. Epub 2007 Oct 29. Infect Immun. 2008. PMID: 17967862 Free PMC article.

7

Catalytic properties of botulinum neurotoxin subtypes A3 and A4.

Henkel JS, Jacobson M, Tepp W, Pier C, Johnson EA, Barbieri JT. Henkel JS, et al. Among authors: barbieri jt. Biochemistry. 2009 Mar 24;48(11):2522-8. doi: 10.1021/bi801686b. Biochemistry. 2009. PMID: 19256469 Free PMC article.

8

Botulinum neurotoxin subtype A2 enters neuronal cells faster than subtype A1.

Pier CL, Chen C, Tepp WH, Lin G, Janda KD, Barbieri JT, Pellett S, Johnson EA. Pier CL, et al. Among authors: barbieri jt. FEBS Lett. 2011 Jan 3;585(1):199-206. doi: 10.1016/j.febslet.2010.11.045. Epub 2010 Nov 30. FEBS Lett. 2011. PMID: 21126520 Free PMC article.

9

Subunit vaccine efficacy against Botulinum neurotoxin subtypes.

Henkel JS, Tepp WH, Przedpelski A, Fritz RB, Johnson EA, Barbieri JT. Henkel JS, et al. Among authors: barbieri jt. Vaccine. 2011 Oct 13;29(44):7688-95. doi: 10.1016/j.vaccine.2011.07.134. Epub 2011 Aug 10. Vaccine. 2011. PMID: 21839134 Free PMC article.

10

Entry of a recombinant, full-length, atoxic tetanus neurotoxin into Neuro-2a cells.

Blum FC, Przedpelski A, Tepp WH, Johnson EA, Barbieri JT. Blum FC, et al. Among authors: barbieri jt. Infect Immun. 2014 Feb;82(2):873-81. doi: 10.1128/IAI.01539-13. Epub 2013 Dec 9. Infect Immun. 2014. PMID: 24478100 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

169 results

Search Page